Enlivex Announces Second Regulatory Approval From Danish Medicines Agency For Global Phase 2b Trial Of Allocetra In Age-Related Primary Knee Osteoarthritis

Benzinga Newsdesk www.benzinga.com Positive 92.2%

Neg 0% Neu 0% Pos 92.2%

Comments

No comments yet. Be the first!